CN103301368B - Medicament for treating hyperactivity - Google Patents
Medicament for treating hyperactivity Download PDFInfo
- Publication number
- CN103301368B CN103301368B CN201310233293.3A CN201310233293A CN103301368B CN 103301368 B CN103301368 B CN 103301368B CN 201310233293 A CN201310233293 A CN 201310233293A CN 103301368 B CN103301368 B CN 103301368B
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- grams
- rhizoma
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating hyperactivity. The medicament comprises the following substances by weight: prepared rehmannia root, golden cypress, Chinese yam, cassia twig, keel, rhizoma acori graminei, moutan bark, poria cocos, root of red-rooted salvia, fructus alpiniae oxyphyllae, pearl, ginseng, schisandra chinensis, gastrodia elata and liquorice. The medicament for treating hyperactivity disclosed by the invention has the characteristics of being low in cost, easy to prepare, small in toxic and side effect and remarkable in curative effect.
Description
Technical field
The present invention relates to tcm field, specifically, relate to a kind of medicament for the treatment of hyperkinetic syndrome.
Background technology
Hyperkinetic syndrome is a kind of chronic brain diseases, is also a kind of children's's nervous system common disease frequently-occurring disease.The traditional Chinese medical science is thought the categories such as hyperkinetic syndrome " restless ", " becoming deaf ", " forgetful ".Due to children's's " flesh bone is tender timid ", " internal organs are weak ", " vital organs of the human body and incomplete; entirely and not strong ", easily void, easily real, easily cold, easily hot, some people's mistake thinks that hyperkinetic syndrome is not disease, idea or the head of a family such as need not treat is afraid of to have Western medicine to liver, kidney damage, incur loss through delay therapy apparatus meeting, affected child's all one's life, all can have adverse influence to family and society.
Summary of the invention
The object of this invention is to provide a kind of medicament for the treatment of hyperkinetic syndrome.
In order to realize object of the present invention, the invention provides a kind of medicament for the treatment of hyperkinetic syndrome, the material that it comprises following weight proportioning: Radix Rehmanniae Preparata 15-20 part, Cortex Phellodendri 15-18 part, Rhizoma Dioscoreae 20-25 part, Ramulus Cinnamomi 20-25 part, Os Draconis 30-35 part, Rhizoma Acori Graminei 25-30 part, Cortex Moutan 10-15 part, Poria 10-15 part, Radix Salviae Miltiorrhizae 20-25 part, Fructus Alpiniae Oxyphyllae 30-35 part, Margarita 40-45 part, Radix Ginseng 20-25 part, Fructus Schisandrae Chinensis 15-20 part, Rhizoma Gastrodiae 20-25 part and Radix Glycyrrhizae 25-30 part.
Preferably, the kit for the treatment of hyperkinetic syndrome of the present invention is containing the material of following weight proportioning: 27 parts, 16 parts of Radix Rehmanniae Preparata, 17 parts of Cortex Phellodendris, 22 parts of Rhizoma Dioscoreaes, 24 parts of Ramulus Cinnamomi, 33 parts of Os Draconis, 28 parts of Rhizoma Acori Graminei, 14 parts of Cortex Moutans, 12 parts, Poria, 23 parts of Radix Salviae Miltiorrhizaes, 31 parts of Fructus Alpiniae Oxyphyllae, 43 parts of Margaritas, 24 parts of Radix Ginsengs, 17 parts of Fructus Schisandrae Chinensis, 22 parts, Rhizoma Gastrodiae and Radix Glycyrrhizae.
More preferably, the medicament for the treatment of hyperkinetic syndrome of the present invention also comprises the material of following weight proportioning: 5 parts of 5 parts of Fructus Broussonetiaes, 6 parts of 3 parts of, Herba Thlaspiss of RADIX PEUCEDANI, 5 parts of Rhizoma Smilacis Chinensiss, 7 parts of Herba Cichoriis, Rhizoma Dioscoreae Septemlobae 46 parts of Fen, Herba Siegesbeckiaes, 3 parts of Herba Gendarussaes, 5 parts of Cortex Syingae Amurensiss, 3 parts of Herba pterocephali, 3 parts of Nodus Nelumbinis Rhizomatis, 7 parts of Medulla Stachyuri (Medulla Helwingiae)s, 4 parts of Flos Bombacis Malabaricis, 5 parts of Concha Arcaes, 3 parts of Caulis Mahoniaes, 6 parts of Folium Sauropis, 7 parts of Semen Lablab Albums, 3 parts of Retinervus Luffae Fructuss, 5 parts of Herba Polygoni cymosis, 3 parts of Semen Celosiae and Fructus Litseae.
More preferably, described medicament can be tablet, dispersible tablet, oral liquid or capsule.
The medicament for the treatment of hyperkinetic syndrome of the present invention has the advantages that cost is low, preparation is easy, toxic and side effects is little, curative effect is showing.
The specific embodiment
Embodiment 1:
Take 270 grams, 160 grams of Radix Rehmanniae Preparata, 170 grams of Cortex Phellodendris, 220 grams of Rhizoma Dioscoreaes, 240 grams of Ramulus Cinnamomi, 330 grams of Os Draconis, 280 grams of Rhizoma Acori Graminei, 140 grams of Cortex Moutans, 120 grams, Poria, 230 grams of Radix Salviae Miltiorrhizaes, 310 grams of Fructus Alpiniae Oxyphyllae, 430 grams of Margaritas, 240 grams of Radix Ginsengs, 170 grams of Fructus Schisandrae Chinensis, 220 grams, Rhizoma Gastrodiae and Radix Glycyrrhizae, add 50000 milliliters, water, the in the situation that of reflux, heat 5 hours, filter, filtrate is concentrated into 5000 milliliters, add 150 grams of sucrose, stir, sterilizing, in fill to 100 bottle, obtain oral liquid of the present invention, wherein every bottle contains 50 milliliters.
Embodiment 2:
Take 160 grams of Radix Rehmanniae Preparata, 170 grams of Cortex Phellodendris, 220 grams of Rhizoma Dioscoreaes, 240 grams of Ramulus Cinnamomi, 330 grams of Os Draconis, 280 grams of Rhizoma Acori Graminei, 140 grams of Cortex Moutans, 120 grams, Poria, 230 grams of Radix Salviae Miltiorrhizaes, 310 grams of Fructus Alpiniae Oxyphyllae, 430 grams of Margaritas, 240 grams of Radix Ginsengs, 170 grams of Fructus Schisandrae Chinensis, 220 grams, Rhizoma Gastrodiae, 270 grams, Radix Glycyrrhizae, 50 grams of Fructus Broussonetiaes, 30 grams of RADIX PEUCEDANI, 60 grams of Herba Thlaspiss, 50 grams of Rhizoma Smilacis Chinensiss, 70 grams of Herba Cichoriis, 40 grams of Rhizoma Dioscoreae Septemlobaes, 60 grams of Herba Siegesbeckiaes, 30 grams of Herba Gendarussaes, 50 grams of Cortex Syingae Amurensiss, 30 grams of Herba pterocephali, 30 grams of Nodus Nelumbinis Rhizomatis, 70 grams of Medulla Stachyuri (Medulla Helwingiae)s, 40 grams of Flos Bombacis Malabaricis, 50 grams of Concha Arcaes, 30 grams of Caulis Mahoniaes, 60 grams of Folium Sauropis, 70 grams of Semen Lablab Albums, 30 grams of Retinervus Luffae Fructuss, 50 grams of Herba Polygoni cymosis, 50 grams of 30 grams of Semen Celosiae and Fructus Litseae, add 50000 milliliters, water, the in the situation that of reflux, heat 5 hours, filter, filtrate is concentrated into 5000 milliliters, add 150 grams of sucrose, stir, sterilizing, in fill to 100 bottle, obtain oral liquid of the present invention, wherein every bottle contains 50 milliliters.
Experimental example
42 routine patients all meet the diagnostic criteria (Chen Guiting of MBD, Yang Sipeng. practical Chinese medicine and western medicine is in conjunction with diagnoses and treatment [M]. Beijing: Chinese Medicine science and technology publishing house, 1991:1138), auxiliary examination: the about 35%-50% of electroencephalogram has abnormal change, turns over hands and tests, refers to that nose-finger finger test, figure are felt experiment, the difficult vertical positive of testing of remaining silent.Wherein male 30 examples, female's 12 examples, age 5-16 year, 12 years old mean age, course of disease 1-8 month.This group case is all made a definite diagnosis through electroencephalogram and clinical sign, gets rid of naughty normal children, tourette's syndrome, epilepsy, mental retardation disease etc.Be divided into two groups, every group of 21 routine patients, two groups are compared there was no significant difference (P > 0.05) in sides such as sex, age, the course of disease, state of an illness scorings, have comparability.
First group of oral liquid prepared by the oral embodiment 1 of patient, every day twice, each 1 bottle, treating 30 days is 1 course for the treatment of, treats 2 courses for the treatment of.
Second group of oral liquid prepared by the oral embodiment 2 of patient, every day twice, each 1 bottle, treating 30 days is 1 course for the treatment of, treats 2 courses for the treatment of.
Criterion of therapeutical effect
1. clinical cure: 1 the course for the treatment of transference cure, electroencephalogram is normal, turns over hands test, refers to the feminine genders such as nose-ringer finger test; 2. take a turn for the better: be used in conjunction 2 the course for the treatment of symptom obviously improve, auxiliary examination all takes a turn for the better; 3. invalid: be used in conjunction 2 the course for the treatment of symptom without improvement, auxiliary examination is without improvement.
Therapeutic outcome
In first group of patient, recovery from illness 15 examples, 6 examples take a turn for the better; In second group of patient, recovery from illness 21 examples.In observation, do not occur serious adverse reaction, after treatment finishes, two groups of patients' blood, urine, stool routine and hepatic and renal function inspection are showed no extremely.
Claims (1)
1. treat the medicament of hyperkinetic syndrome for one kind, it is characterized in that it is made up of the material of following weight proportioning: 16 parts of Radix Rehmanniae Preparata, 17 parts of Cortex Phellodendris, 22 parts of Rhizoma Dioscoreaes, 24 parts of Ramulus Cinnamomi, 33 parts of Os Draconis, 28 parts of Rhizoma Acori Graminei, 14 parts of Cortex Moutans, 12 parts, Poria, 23 parts of Radix Salviae Miltiorrhizaes, 31 parts of Fructus Alpiniae Oxyphyllae, 43 parts of Margaritas, 24 parts of Radix Ginsengs, 17 parts of Fructus Schisandrae Chinensis, 22 parts, Rhizoma Gastrodiae, 27 parts, Radix Glycyrrhizae, 5 parts of Fructus Broussonetiaes, 3 parts of RADIX PEUCEDANI, 6 parts of Herba Thlaspiss, 5 parts of Rhizoma Smilacis Chinensiss, 7 parts of Herba Cichoriis, 4 parts of Rhizoma Dioscoreae Septemlobaes, 6 parts of Herba Siegesbeckiaes, 3 parts of Herba Gendarussaes, 5 parts of Cortex Syingae Amurensiss, 3 parts of Herba pterocephali, 3 parts of Nodus Nelumbinis Rhizomatis, 7 parts of Medulla Stachyuri (Medulla Helwingiae)s, 4 parts of Flos Bombacis Malabaricis, 5 parts of Concha Arcaes, 3 parts of Caulis Mahoniaes, 6 parts of Folium Sauropis, 7 parts of Semen Lablab Albums, 3 parts of Retinervus Luffae Fructuss, 5 parts of Herba Polygoni cymosis, 5 parts of 3 parts of Semen Celosiae and Fructus Litseae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310233293.3A CN103301368B (en) | 2013-06-14 | 2013-06-14 | Medicament for treating hyperactivity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310233293.3A CN103301368B (en) | 2013-06-14 | 2013-06-14 | Medicament for treating hyperactivity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103301368A CN103301368A (en) | 2013-09-18 |
| CN103301368B true CN103301368B (en) | 2014-07-02 |
Family
ID=49127374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310233293.3A Expired - Fee Related CN103301368B (en) | 2013-06-14 | 2013-06-14 | Medicament for treating hyperactivity |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103301368B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104524245B (en) * | 2014-12-28 | 2017-08-01 | 重庆第二师范学院 | Chinese medicine composition and its preparation for treating children ADHD |
| CN105998790A (en) * | 2016-06-18 | 2016-10-12 | 王甜甜 | Traditional Chinese medicine for treating attention deficit hyperactivity disorder and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101024016A (en) * | 2007-03-26 | 2007-08-29 | 殷彬 | Chinese for treating infaut's attention deficit hyperactivity disorder |
| CN101322806A (en) * | 2008-07-24 | 2008-12-17 | 刘富生 | Chinese medicine for treating epilepsy and hyperkinetic symptom of children |
| CN101879268A (en) * | 2010-07-13 | 2010-11-10 | 辽宁东方人药业有限公司 | Method for preparing Chinese medicinal oral liquid for treating attention deficit hyperactivity disorder |
-
2013
- 2013-06-14 CN CN201310233293.3A patent/CN103301368B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101024016A (en) * | 2007-03-26 | 2007-08-29 | 殷彬 | Chinese for treating infaut's attention deficit hyperactivity disorder |
| CN101322806A (en) * | 2008-07-24 | 2008-12-17 | 刘富生 | Chinese medicine for treating epilepsy and hyperkinetic symptom of children |
| CN101879268A (en) * | 2010-07-13 | 2010-11-10 | 辽宁东方人药业有限公司 | Method for preparing Chinese medicinal oral liquid for treating attention deficit hyperactivity disorder |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103301368A (en) | 2013-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102284050B (en) | Chinese medicine composition for treating infertility caused by cold uterus | |
| CN101785810B (en) | Traditional Chinese medicine preparation for anaphylactoid purpura treatment | |
| CN103385999B (en) | Chinese medicine composition for treating acute mastitis | |
| CN103301368B (en) | Medicament for treating hyperactivity | |
| CN103341037B (en) | Traditional Chinese medicine composition for treating azoospermia | |
| CN103272136B (en) | Traditional Chinese medicine for treating climacteric syndrome of women | |
| CN101804189A (en) | Drug for treating primary dysmenorrhea | |
| CN103893457A (en) | Traditional Chinese medicine for treating ulcerative colitis | |
| CN103356925A (en) | Traditional Chinese medicine composition for treating sperm non-liquified symptom | |
| CN103893601B (en) | A kind of medicament for the treatment of mumps | |
| CN103463340B (en) | One treats migrainous Chinese medicine preparation | |
| CN103585495B (en) | Capsule for treating diabetic kidney damage | |
| CN105770748A (en) | Traditional Chinese medicine composition for treating gouts | |
| CN102302744B (en) | Chinese medicinal preparation for treating chronic cholecystitis | |
| CN103830684B (en) | One treats menorrheal pharmaceutical composition and application thereof | |
| CN104436121A (en) | Medicine for treating irregular menstruation, lower abdominal distension and persistent failure to conceive | |
| CN104162043A (en) | Traditional Chinese medicine used for treatment of allergic nodular cutaneous vasculitis | |
| CN104208640A (en) | Traditional Chinese medicine composition for treating delayed menstrual cycle | |
| CN103341126A (en) | Chinese medicine composite for treating chronic gastritis and preparation method thereof | |
| CN103520538B (en) | A kind ofly treat the pharmaceutical composition that diabetes cause kidney damage | |
| CN102836403B (en) | Chinese medicine for treating chronic nephritis by using root of low greenbrier | |
| CN105688096A (en) | Traditional Chinese medicine composition for treating gout | |
| CN104740579A (en) | Premenstrual calming tablet and preparation process thereof | |
| CN105232609A (en) | Traditional Chinese medicine combination treating functional dyspepsia | |
| CN105147971A (en) | Traditional Chinese medicine preparation for treating infantile suppurative tonsillitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140702 Termination date: 20170614 |